Using a special stent to help reverse gastric bypass surgery
Official title: Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass: a Proof of Concent Study
Run by University Hospital, Ghent · NCT05640947 · Data updated 2026-11-12
This study is testing whether a special stent can help people who need their gastric bypass reversed feel better and improve their nutrition without needing surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 2 sites (Bruges and 1 other locations) |
| Status | Recruiting |
| Started | January 30, 2023 |
| Main results expected | October 2027 |
| Study ends | February 2028 |
| Registry record updated | October 8, 2025 |
| Trial ID | NCT05640947 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients requiring parenteral nutritional support, those with symptomatic dumping syndrome, patients with refractory marginal ulcers, and individuals with severe liver fibrosis post-bypass.
✕Probably not a fit
Patients with uncorrectable coagulopathy or significant portal hypertension may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to evaluate the effectiveness of an endoscopically placed lumen-apposing metal stent as a non-surgical alternative for patients requiring reversal of their gastric bypass. The study focuses on patients with specific conditions such as hypoglycemia, gastric outlet obstruction, and severe liver fibrosis. Participants will receive the Hot AXIOS™ Stent and Electrocautery-Enhanced Delivery System to assess the stent's ability to alleviate symptoms and improve nutritional status. The study is open-label, meaning both researchers and participants will know the treatment being administered.
Why it matters
Potential benefit: If successful, this approach could provide a less invasive option for patients needing gastric bypass reversal, potentially improving their quality of life.
How similar studies have gone: While this approach is innovative, similar studies exploring endoscopic interventions for gastric bypass complications have shown promise, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Group 1) patients needing any kind of parenteral nutritional support (eg. hypo- albuminemia, hypovitaminoses, mineral deficiencies,...) that can not be corrected by dietary intervention/oral supplementation * Group 2) patients with persistent invalidating symptomatic dumping syndrome despite optimal dietary intervention (typical complaints are headache, sweating, trembling, weakness and feeling hungry). * Group 3) patients with a refractory marginal ulcers with stenosis of the gastrojejunostomy leading to feading difficulties. * Group 4) patients with F3 or F4 liver fibrosis and a tendency to decompensation after bypass surgery, as demonstrated by an increase in serum bilirubin/INR and/or lowering of serum albumin. Exclusion Criteria: 1. Uncorrectable coagulopathy 2. Presence of significant portal hypertension as demonstrated by 2.1) the presence of esophageal and/or gastric varices AND/OR 2.2) a hepatic venous pressure gradient (if measured) equal to or more than 10mm Hg AND/OR 2.3) the combination of 1. a platelet count \<150000/µl AND 2. liver stiffness measured by elastometry equal to or more than 20 kPa (Baveno guidelines). 3. Pregnant women, breastfeeding women or women that can not assure adequate anticonception for the duration of the study (based on anamnesis). 4. Karnofsky index less than 60 5. Vulnerable patients
Where it's running
-
AZ Sint-Jan Brugge
Bruges, Belgium Recruiting -
University Hospital, Ghent
Ghent, Belgium Recruiting
Study contacts
- Principal investigator: Pieter Hindryckx, Prof. — University Hospital, Ghent
- Study coordinator: Pieter Hindryckx, Prof.
- Email: pieter.hindryckx@uzgent.be
- Phone: 093320726
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery
This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.
-
Stomach-Partitioning Surgery to Help Block Obstruction in Advanced Stomach Cancer
This trial tests whether stomach-partitioning gastrojejunostomy helps people with unresectable, advanced stomach cancer better tolerate food after surgery than the standard approach.
-
Gastrointestinal Magnet System for Creating a Gastroenterostomy
This study tests the GT Metabolic Magnet System to see if it can safely create a side-to-side gastroenterostomy for adults with gastric outlet obstruction.
-
Fear of hypoglycemia in people with diabetes
This study looks at how fear of low blood sugar affects how people with diabetes take their medications and manage their diet.
-
GT Metabolic Magnet System to create side-to-side connections in the stomach or small intestine
This study will test whether the GT Metabolic Magnet System can safely create side-to-side connections in the stomach or small intestine for adults with gastric outlet obstruction, partial small bowel obstruction, or superior mesenteric artery syndrome.
-
How sexual activity affects low blood sugar risk in adults with insulin-treated diabetes who use a CGM
This study will see if sexual activity changes the risk of low blood sugar in adults with type 1 or type 2 diabetes who use insulin and a continuous glucose monitor.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.